GLOMERULAR DYNAMICS AND MORPHOLOGY OF AGED SPONTANEOUSLY HYPERTENSIVE RATS - EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION

Relationships between glomerular dynamics and renal injury, micropuncture and histological studies were assessed in 73 week-old normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats divided into untreated and angiotension-converting enzyme inhibitor-treated (quinapril; 3 mg/kg/day; for 3 weeks) groups. Urinary protein excretion (UPE) and histologic arteriolar (AIS) and glomerular (GIS) injury scores were determined. Mean arterial pressure (MAP) of untreated SHR was increased compared with WKY (200+/-6 vs 119+/-4 mm Hg; P<0.01), effective renal plasma flow (ERPF) was reduced (1.47+/-0.21 vs 3.06+/-0.26 ml/min/per g; P>0.01), and filtration fraction (FF) and total renal vascular resistance (RVR) of SHR were increased (P<0.01). Single-nephon plasma flow (SNPF) of untreated SHR was decreased (174+/-17 vs 80+/-9 ml/min; P<0.01), and single-nephron filtration fraction and afferent arteriolar resistance (R(A)) were increased (19.4+/-1.8 vs 30.0+/-2.5% and 1.90+/-0.25 vs 9.05+/-1.35 U, respectively; both P<0.01). Despite reduced SNPF, glomerular capillary pressure (P-G) increased (49.7+/-0.7 vs 53.8+/-1.3 mm Hg; P<0.05), the result of efferent arteriolar constriction (1.15+/-0.18 vs 2.84+/-0.36 U; P<0.01). Untreated SHR had higher UPE (13.9+/-1.5 vs 42.8+/-3.2; mg/100 g per day; P<0.01) and GIS and AIS scores than WKY (4.3+/-1.1 vs 64.3+/-8.4 and 16.6+/-3.1 vs 96.3+/-14.4; both P<0.01). Quinapril reduced SHR MAP (to 173+/-7 mm Hg), FF and RVR (all P<0.01) and increased ERPF (to 2.40+/-0.26 ml/min per g; P<0.05), and P-G decreased (to 49.1+/-1.1 mm Hg; P<0.01); in association with R(A) and R(E) (to 5.18+/-0.8 U; P<0.01 and 1.74+/-0.31 U; P<0.05). Although quinapril reduced UPE (to 23.6+/-1.8 mg/100 g per day; P<0.01) with GIS and AIS (P<0.05) in SHR, these indices remained higher than in WKY. These data demonstrate that SHR naturally develop glomerular hypertension and ischemia with arteriolar constriction and glomerular sclerosis, and that intrarenal hemodynamic, pathologic, and proteinuric changes begin to reverse after 3 weeks of treatment.